Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
6.51
+0.30 (4.83%)
At close: Oct 31, 2025, 4:00 PM EST
6.45
-0.06 (-0.92%)
Pre-market: Nov 3, 2025, 8:49 AM EST
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts that cover Capricor Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $23, which forecasts a 253.30% increase in the stock price over the next year. The lowest target is $12 and the highest is $30.
Price Target: $23 (+253.30%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 25, 2025.
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +268.66% | Sep 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +268.66% | Sep 11, 2025 |
| Roth Capital | Roth Capital | Strong Buy Maintains $31 → $12 | Strong Buy | Maintains | $31 → $12 | +84.33% | Jul 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $77 → $24 | Strong Buy | Maintains | $77 → $24 | +268.66% | Jul 11, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +222.58% | Jun 26, 2025 |
Financial Forecast
Revenue This Year
1.35M
from 22.27M
Decreased by -93.94%
Revenue Next Year
107.84M
from 1.35M
Increased by 7,894.07%
EPS This Year
-2.22
from -1.15
EPS Next Year
-1.84
from -2.22
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3M | 314.5M | |||
| Avg | 1.3M | 107.8M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -71.7% | 23,212.1% | |||
| Avg | -93.9% | 7,894.1% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.94 | -0.92 | |||
| Avg | -2.22 | -1.84 | |||
| Low | -2.32 | -2.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.